싸토리우스코리아

Thank you - Your Download is Available Below

Development of an End-to-End Scalable Purification Platform for Extracellular Vesicles

PDF | 801.2 KB

Development of an End-to-End Scalable Purification Platform for Extracellular Vesicles

Extracellular vesicles (EVs) are being evaluated as novel therapeutics for a variety of diseases due to low immunogenicity, low toxicity, and increased circulation stability. However, the characterization and purification of EVs is quite challenging. Sartorius, a frontrunner in EV process development, provides end-to-end solutions and expertise for EV production, purification, and characterization.

Robust analytical platform for EV characterization
Robust purification to maximize yield and purity
Process expertise and consulting

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

Development of an End-to-End Scalable Purification Platform for Extracellular Vesicles

Development of an End-to-End Scalable Purification Platform for Extracellular Vesicles

Please Complete the Form

Complete Form to Access the File